hsa_circ_0000677

ncRNA information

ncRNA name

hsa_circ_0000677

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

Wnt/Ī²-catenin signaling pathway

Cancer information

Cancer name

Osteosarcoma

Cancer site

Bone, Articular Cartilage

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Upregulation of circ_001569 significantly promoted osteosarcoma cell resistance to cisplatin by activating Wnt/Ī²-catenin signaling pathway. Thus, these results indicated that circ_001569 represented a novel potentially therapeutic target of osteosarcoma.

Tissue resource

primary osteosarcoma tissue samples and adjacent non-cancerous bone tissue samples

human osteosarcoma cell lines MG-63

human osteosarcoma cell lines U2OS

normal human osteoblastic cell lines hFOB

Experiment

qRT-PCR,Western blot


Institute

Affiliated Hospital of Weifang Medical University

Type Culture Collection of the Chinese Academy of Sciences

Country

China

Continent

Asia